Search research articles
Contact Us
Filters
Showing results (191-200 of 222) with videos related to
Page
of 23
Sort By:
World Journal of Urology
|
November 14, 2021
Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
Klaus-Peter Dieckmann, Cansu Dumlupinar, Arlo Radtke, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare
|
January 19, 2024
Debriefing Methods for Simulation in Healthcare: A Systematic Review
Jonathan P Duff, Kate J Morse, Julia Seelandt, et al.
Scientific Reports
|
September 5, 2023
Subsets of preoperative sex hormones in testicular germ cell cancer: a retrospective multicenter study
Péter Törzsök, David Oswald, Klaus-Peter Dieckmann, et al.
The Journal of Urology
|
December 18, 2019
Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series Data
Christian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
The Journal of Urology
|
February 1, 2020
Reply by Authors
Christian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
European Urology
|
June 27, 2021
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review
Ricardo Leão, Maarten Albersen, Leendert H J Looijenga, et al.
European Urology
|
August 7, 2016
Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
Klaus-Peter Dieckmann, Arlo Radtke, Meike Spiekermann, et al.
European Urology
|
February 18, 2017
Corrigendum re: "Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours" [Eur Urol 2017;71:213-20]
Klaus-Peter Dieckmann, Arlo Radtke, Meike Spiekermann, et al.
World Journal of Urology
|
September 15, 2022
Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review
Christian G Ruf, Stefanie Schmidt, Sabine Kliesch, et al.
European Urology Focus
|
May 10, 2024
Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours
Klaus-Peter Dieckmann, Francesca Grobelny, Armin Soave, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 222) with videos related to
Sort By:
Page
of 23
World Journal of Urology
|
November 14, 2021
Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
Klaus-Peter Dieckmann, Cansu Dumlupinar, Arlo Radtke, et al.
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare
|
January 19, 2024
Debriefing Methods for Simulation in Healthcare: A Systematic Review
Jonathan P Duff, Kate J Morse, Julia Seelandt, et al.
Scientific Reports
|
September 5, 2023
Subsets of preoperative sex hormones in testicular germ cell cancer: a retrospective multicenter study
Péter Törzsök, David Oswald, Klaus-Peter Dieckmann, et al.
The Journal of Urology
|
December 18, 2019
Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series Data
Christian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
The Journal of Urology
|
February 1, 2020
Reply by Authors
Christian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
European Urology
|
June 27, 2021
Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review
Ricardo Leão, Maarten Albersen, Leendert H J Looijenga, et al.
European Urology
|
August 7, 2016
Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
Klaus-Peter Dieckmann, Arlo Radtke, Meike Spiekermann, et al.
European Urology
|
February 18, 2017
Corrigendum re: "Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours" [Eur Urol 2017;71:213-20]
Klaus-Peter Dieckmann, Arlo Radtke, Meike Spiekermann, et al.
World Journal of Urology
|
September 15, 2022
Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review
Christian G Ruf, Stefanie Schmidt, Sabine Kliesch, et al.
European Urology Focus
|
May 10, 2024
Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours
Klaus-Peter Dieckmann, Francesca Grobelny, Armin Soave, et al.
Page
of 23